Suppr超能文献

人类病理学中的 PD-1/PD-L1 通路。

The PD-1/PD-L1 pathway in human pathology.

机构信息

Don C Gnocchi Foundation, ONLUS, Milan, Italy.

出版信息

Curr Mol Med. 2012 Mar;12(3):259-67. doi: 10.2174/156652412799218903.

Abstract

T-cell activation is dependent on signals delivered through the antigen-specific T-cell receptor and accessory receptors on T-cells. Integration of signals through this family of costimulatory and inhibitory receptors and their ligands regulates the balance between T-cell activation, tolerance, and immunopathology. Programmed death 1 (PD-1) and its ligands, PD-L1 and PD-L2, deliver inhibitory signals and exert a vital and diverse range of immunoregulatory roles in T-cell activation, tolerance, and immune-mediated tissue damage. In this review, we revisit current understanding of the immunoregulatory functions of PD-1 and its ligands and their involvement in immune-mediated diseases.

摘要

T 细胞的激活依赖于抗原特异性 T 细胞受体和 T 细胞上辅助受体传递的信号。通过这一系列共刺激和抑制性受体及其配体传递的信号整合调节了 T 细胞激活、耐受和免疫病理之间的平衡。程序性死亡受体 1(PD-1)及其配体 PD-L1 和 PD-L2 传递抑制信号,并在 T 细胞激活、耐受和免疫介导的组织损伤中发挥重要且多样的免疫调节作用。在这篇综述中,我们重新审视了 PD-1 及其配体的免疫调节功能及其在免疫介导性疾病中的作用的现有认识。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验